Leo Meriranta

6PUBLICATIONS
29CO-AUTHORS
Haematological tumoursPredictive and prognostic markersLiquid biopsies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|May 22, 2025
Circulating tumor DNA determinants of response and outcome in relapsed/refractory mantle cell lymphoma.

Leo Meriranta, Rasmus Rask Kragh Jørgensen, Annika Pasanen

|May 13, 2025
Biomarker-adapted treatment in high-risk large B-cell lymphoma.

Sirpa Leppä, Leo Meriranta, Maare Arffman

|Apr 17, 2024
Disruption of KLHL6 Fuels Oncogenic Antigen Receptor Signaling in B-Cell Lymphoma.

Leo Meriranta, Selma Sorri, Kanutte Huse

|Dec 19, 2023
MRD-driven treatment with venetoclax-R2 in mantle cell lymphoma: the Nordic Lymphoma Group MCL7 VALERIA trial.

Mats Jerkeman, Arne Kolstad, Martin Hutchings

Pageof 1